XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3

STOCKHOLDERS’ EQUITY (Tables)

9 Months Ended

Sep. 30, 2025

Equity [Abstract]

Schedule of stock option award activity

Schedule of stock option award activity
		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Life In Years
Outstanding December 31, 2024			3,071,635			$	1.02				7.26
Issued			875,539				1.39				4.55
Exercised			-				-				-
Expired or cancelled			(33,557	)			0.89				-
Outstanding September 30, 2025			3,913,617			$	1.10				6.11

Schedule of additional information about stock options

	Schedule of additional information about stock options
Exercise Price				Outstanding Number of Options				Weighted Average Remaining Life In Years				Exercisable Number of Options
$	0.89				2,181,208			$	7.76				1,118,568
	0.94				581,250				3.20				581,250
	0.66				90,620				3.99				-
	2.95				185,000				4.24				125,000
	3.25				130,000				2.80				130,000
	1.15				430,435				4.81				180,000
	0.96				315,104				4.92				315,104
					3,913,617			$	6.11				2,449,922

Schedule of assumptions utilized for stock options award

Schedule of assumptions utilized for stock options award
		September 30, 2025
Volatility			192.2-194.8	%
Expected dividends		$	-
Risk-free interest rate			3.68 - 3.89	%
Expected term (years)			3-5

Schedule of warrants

Schedule of warrants
		Number of warrants				Weighted Average Exercise Price
Outstanding December 31, 2024			2,662,250			$	4.15
Issued			-				-
Exercised			-				-
Expired or cancelled			2,662,250				4.15
Outstanding September 30, 2025			-			$	-

X

- References

No definition available.

+ Details

Name:	nxl_ScheduleOfAdditionalIinformationTableTextBlock
Namespace Prefix:	nxl_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration